Lifeward (LFWD) Cash & Current Investments (2014 - 2026)
Lifeward (LFWD) reported Cash & Current Investments of $11.4 million for Q1 2026, up 100.39% on a YoY basis from $5.7 million in Q1 2025, and up 426.6% sequentially from $2.2 million in Q4 2025.
Lifeward (LFWD) Cash & Current Investments (2014 - 2026) Analysis & Trends
Lifeward (LFWD) has 13 years of Cash & Current Investments data on file, last reported at $11.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 100.39% year-over-year to $11.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.4 million (up 100.39% YoY), and the FY2025 full-year result was $2.2 million, down 67.85% from the prior year.
- Cash & Current Investments rose to $11.4 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $82.6 million in Q1 2022 to a low of $2.0 million in Q3 2025.
- A 5-year average of $33.2 million and a median of $20.7 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 81.31% in 2025 and surged 100.39% in 2026, its largest moves.
- Tracing LFWD's Cash & Current Investments over 5 years: stood at $67.9 million in 2022, then tumbled by 58.64% to $28.1 million in 2023, then sank by 75.98% to $6.7 million in 2024, then plunged by 67.85% to $2.2 million in 2025, then surged by 426.6% to $11.4 million in 2026.
- Business Quant data shows LFWD's Cash & Current Investments at $11.4 million in Q1 2026, $2.2 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 1.12 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Lifeward | 11.56 Mn | 137,830.56 | 1.34 Mn | 11.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.42 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 5.14 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | 10.70 Mn |
| Jun 30, 2024 | 15.13 Mn |
| Mar 31, 2024 | 20.70 Mn |
| Dec 31, 2023 | 28.08 Mn |
| Sep 30, 2023 | 32.60 Mn |
| Jun 30, 2023 | 58.20 Mn |
| Mar 31, 2023 | 61.90 Mn |
| Dec 31, 2022 | 67.90 Mn |
| Sep 30, 2022 | 74.00 Mn |
| Jun 30, 2022 | 78.83 Mn |
| Mar 31, 2022 | 82.63 Mn |
| Dec 31, 2021 | 88.34 Mn |
| Sep 30, 2021 | 91.23 Mn |
| Jun 30, 2021 | 64.24 Mn |